Human GRO-alpha ELISA Kit ELH-GROa from RayBiotech | Biocompare.com

Supplier Images
Published Figures

Image URL

Be the first to write a review!

Citations:

Figures:

Supplier Page from
RayBiotech for
Human GRO-alpha ELISA Kit

Description

RayBio® Human GRO alpha (CXCL1) ELISA Kit for cell culture supernatants, plasma, and serum samples. Lead time: Typically ships within 1-2 business days. No Friday shipments

Product Specs
ItemHuman GRO-alpha ELISA Kit
CompanyRayBiotech
Price $469.00Supplier Page View Company Product Page
Catalog NumberELH-GROa
Quantity1 Plate Kit, 2 Plate Kit, 5 Plate Kit
ReactivityHuman
ApplicationsSandwich ELISA
Sample TypeCell Culture Supernatants, Plasma, Serum
Detection Range2 pg/ml - 1000 pg/ml
Detection TargetCXCL1 (GRO alpha / KC / CINC-1)
NCBI Full Gene NameC-X-C motif chemokine ligand 1
NCBI Gene AliasesSCYB1, MGSA-a, GROa, NAP-3, FSP, GRO1, MGSA
Sensitivity2 pg/ml
Research AreaChemokine Biology, Inflammation

Add to Compare List

RayBiotech

RayBiotech

3607 Parkway Lane, Ste. 200

Peachtree Corners, Georgia 30092

United States

Phone: 770-729-2992
888-494-8555

Company Profile

Website: www.RayBiotech.com

(1) LAMC1 upregulation via TGFβ induces inflammatory cancer‐associated fibroblasts in esophageal squamous cell carcinoma via NF‐κB–CXCL1–STAT3Molecular OncologyNovember 1, 2021Lingling Fang, Yun Che, Chaoqi Zhang, Jianbing Huang, Yuanyuan Lei, Zhiliang Lu, Nan Sun, Jie Hecollected at 48 h for measurement of CXCL1 protein (without dilution) with a Human GRO‐alpha ELISA kit (ELH‐GROa, RayBio, Guangzhou, China). Each sample had duplicate wells for the standard curve and experimental

(2) Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapyNature communicationsFebruary 28, 2020Li M, Li S, Zhou H, Tang X, Wu Y, Jiang W, Tian Z, Zhou X, Yang X, Wang Y.

(3) Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expressionOncogeneAugust 4, 2016Duckworth C, Zhang L, Carroll SL, Ethier SP, Cheung HW.

(4) Altered release of chemokines by phagocytes from fibromyalgia patients: a pilot studyInnate immunityJanuary 1, 2016García JJ, Carvajal-Gil J, Guerrero-Bonmatty R.

(5) Diagnostic Value of Circulating CXC Chemokines in Non-small Cell Lung CancerAnticancer researchDecember 1, 2015Spaks A, Jaunalksne I, Spaka I, Chudasama D, Pirtnieks A, Krievins D.

(6) Human Umbilical Cord-Derived Mesenchymal Stem Cells Improve Learning and Memory Function in Hypoxic-Ischemic Brain-Damaged Rats via an IL-8-Mediated Secretion Mechanism Rather than Differentiation Pattern InductionCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2015Zhou X, Gu J, Gu Y, He M, Bi Y, Chen J, Li T.

(7) Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivoThe Journal of biological chemistryOctober 11, 2013Maussang D, Mujić-Delić A, Descamps FJ, Stortelers C, Vanlandschoot P, Stigter-van Walsum M, Vischer HF, van Roy M, Vosjan M, Gonzalez-Pajuelo M, et al.

(8) Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancerMolecular cancer therapeuticsJuly 1, 2012LaValle CR, Zhang L, Xu S, Eiseman JL, Wang QJ.

(9) Interleukin (IL)-17 versus IL-27: opposite effects on tumor necrosis factor-α-mediated chemokine production in human keratinocytesExperimental dermatologyJanuary 1, 2012Fujiwara S, Nagai H, Oniki S, Yoshimoto T, Nishigori C.

Be the First to Write a Review!